CXCR4 and chronic kidney disease: The anti-CXCR4 i-body AD-114 was developed and demonstrated to have anti-fibrotic activity in a mouse model of pulmonary fibrosis, and in one of our previous studies [26], we demonstrated the anti-fibrotic effect of i-body AD-114 in an FA-induced CKD model [15].